Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1999
03/18/1999WO1998046722A9 Direct expression of peptides into culture media
03/18/1999WO1998044103A3 Protein for inhibiting apoptosis
03/18/1999DE19740735A1 Antibodies specific for Borrelia burgdorferi 24 kD antigen OspC
03/18/1999DE19740030A1 Ampullosporin, Verfahren zu dessen Herstellung und dessen Verwendung Ampullosporin, process for its preparation and its use
03/18/1999DE19739940A1 Protein mit Aminosäuresequenz der DELTA7-Sterolreduktase, isoliertes cDNA-Molekül, das für das Protein kodiert, rekombinanter DNA-Vektor und biologisch aktive Zusammensetzungen, die das Protein oder das cDNA-Molekül enthalten Protein having amino acid sequence of Delta7-Sterolreduktase, isolated cDNA molecule which encodes the protein A recombinant DNA vector, and biologically active compositions containing the protein or cDNA molecule
03/18/1999DE19738710A1 A novel T-cell transmembrane protein (TIRC7)
03/18/1999CA2323936A1 Estrogen receptor
03/18/1999CA2304108A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999CA2303618A1 Improvements in or relating to expression of immunogenic substances
03/18/1999CA2303617A1 Improvements in or relating to regulation of t cell activation
03/18/1999CA2303616A1 Transplacental delivery of oligonucleotides
03/18/1999CA2303615A1 April- a novel protein with growth effects
03/18/1999CA2303486A1 Stabilization of helicobacter urease
03/18/1999CA2303480A1 Mpl ligand analogs
03/18/1999CA2303479A1 Human sigma receptor
03/18/1999CA2303462A1 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases
03/18/1999CA2303424A1 Kay - a novel immune system protein
03/18/1999CA2303422A1 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999CA2303410A1 Mucosal cytotoxic t lymphocyte responses
03/18/1999CA2303409A1 Class i-type lysyl-trna synthetase
03/18/1999CA2303402A1 Hypoxia inducible promoter
03/18/1999CA2303396A1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999CA2302807A1 Dsrna/dsrna-binding protein methods and compositions
03/18/1999CA2302752A1 Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
03/18/1999CA2302705A1 Secreted proteins and polynucleotides encoding them
03/18/1999CA2302647A1 Expression of gonadotropins in dictyostelium
03/18/1999CA2302423A1 Methods for increasing cd4+ t-lymphocyte counts in hiv-infected patients by the administration of gm-csf
03/18/1999CA2302148A1 Human papilloma virus inhibition by anti-sense oligonucleotides
03/18/1999CA2301979A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999CA2301969A1 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds
03/18/1999CA2301883A1 Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
03/18/1999CA2301684A1 Peptides comprising an immunodominant sequence derived from human myelin oligodendrocyte glycoprotein
03/18/1999CA2301173A1 Cysteine rich receptors-train
03/18/1999CA2300804A1 Monoclonal antibodies that bind testosterone
03/18/1999CA2300387A1 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
03/18/1999CA2300221A1 Retro-inverso neurotrophic and analgesic peptides
03/18/1999CA2247551A1 Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
03/18/1999CA2244325A1 Novel amps
03/18/1999CA2244323A1 Novel gapdh
03/18/1999CA2244241A1 Novel phoh
03/17/1999EP0902289A2 Additive formulation comprising heparin-specific glucanase and use thereof
03/17/1999EP0902088A2 Peptides with antiproliferative properties
03/17/1999EP0902087A2 Histidine kinase
03/17/1999EP0902086A1 Tuberculosis vaccine
03/17/1999EP0902085A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/17/1999EP0902036A1 Peptide containing an arginine mimetic for the treatment of osteoporosis, their production, and drugs containing these compounds
03/17/1999EP0901628A1 Phosphotyrosine mimics and methods for identifying and using same
03/17/1999EP0901530A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
03/17/1999EP0901526A1 Cortistatin: neuropeptides, compositions and methods
03/17/1999EP0901525A2 Peptide antagonists derived from the transmembrane domains of g protein-coupled receptors
03/17/1999EP0901504A1 Zona pellucida proteins for contraception
03/17/1999EP0901502A1 Lytic peptides
03/17/1999EP0901463A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
03/17/1999EP0901405A1 Fibrinogen apparatus, method and container
03/17/1999EP0901379A2 Type-2 chemokine binding proteins and methods of use therefor
03/17/1999EP0901378A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
03/17/1999EP0901370A1 Stimulation of immune response with low doses of il-2
03/17/1999EP0819003A4 A method for the treatment of macular degeneration
03/17/1999EP0779076A4 Peptide, a method of obtaining it and a pharmaceutical compound based on it
03/17/1999EP0733065B1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
03/17/1999EP0728148B1 Improved immunogenic compositions against human gastrin 17
03/17/1999EP0717634A4 Injectable compositions for soft tissue augmentation
03/17/1999EP0688226B1 Protein preparation for the prevention and therapy of periodontitis or other bacterial pathologies of the oral cavity
03/17/1999EP0675899B1 NOVEL INHIBITORS OF FACTOR Xa
03/17/1999EP0618806B1 A stabilized pharmaceutical formulation comprising growth hormone and asparagine
03/17/1999EP0616613B1 Fragments of prion proteins
03/17/1999EP0616536B1 Use of decorin or biglycan for the manufacture of a medicament in the treatment of diabetes-associated pathology
03/17/1999EP0565634B1 Angiotensin ii receptor blocking compositions
03/17/1999EP0485611B1 Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof
03/17/1999CN1211280A Thrombin muteins as antidotes for thrombin inhibitors
03/17/1999CN1211279A Composition and methods for the treatment and diagnosis of breast cancer
03/17/1999CN1211255A Ob receptor and method of diagnosing and treating weight
03/17/1999CN1211193A Contraceptive release systems with antibacterial and/or antiviral effect
03/17/1999CN1211191A Gel formulations containing growth factors
03/17/1999CN1211184A Use of leukotriene B4 or its analogues as antiviral and antineoplastic agents
03/17/1999CN1210889A Method for preparing monomer insulin
03/17/1999CA2244330A1 Novel histidine kinase
03/17/1999CA2215898A1 Medicament
03/16/1999US5883293 Conformationally constrained backbone cyclized peptide analogs
03/16/1999US5883239 aroA
03/16/1999US5883230 Multidomain hematopoiesis stimulators
03/16/1999US5883229 Bcl-y is involved in mediating cell death or survival
03/16/1999US5883228 Functionally active regions of signal transducer and activator of transcription
03/16/1999US5883227 Multiple sclerosis associated polypeptide
03/16/1999US5883225 Polypeptides and sequence
03/16/1999US5883224 Characterization of transfer factors and methods of use
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883119 Triterpene derivatives with immunosuppressant activity
03/16/1999US5883107 Antithrombotic agents
03/16/1999US5883082 Compositions and methods for preventing and treating allograft rejection
03/16/1999US5883081 Isolation of novel HIV-2 proviruses
03/16/1999US5883079 Method for inhibiting H. pylori infection in mammalian tissue
03/16/1999US5883078 Hemostyptic and tissue adhesive
03/16/1999US5883077 Peptides aldehyde analogues
03/16/1999US5883075 Hypotensive agent cyclic peptides
03/16/1999US5883074 Potentiators of antibacterial agents
03/16/1999US5883073 Single-chain double-alpha peptide
03/16/1999US5883071 Mammalian growth factor
03/16/1999US5882944 Methods for G protein coupled receptor activity screening
03/16/1999US5882927 Oligonucleotide inhibition of protein kinase C
1 ... 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 ... 3163